![](https://investorshub.advfn.com/uicon/632715.png?cb=1505107773)
Wednesday, March 09, 2022 12:53:39 PM
I’m not sure if people understand how large the Sawston facility actually is, so I’ll throw some comparability numbers out there. Sawston is roughly double the size of Kite’s 44,000 square foot El Segundo CAR-T manufacturing facility, which Kite estimates is large enough to produce about 4,000 personalized cell therapy treatments annually. The shell size alone shouldn’t be used to compare with potential DCVax manufacturing capability, because this doesn’t account for the difference in manufacturing time or potential space utilization.
It seems reasonable to think that with process optimization using Flaskworks and other automated processes, DCVax-L manufacture time may be reduced from 8 days to 7 days, which is less than half the manufacturing time of Yescarta’s ~16 days. So given that Sawston is double the size and it takes half the time to manufacture DCVax, then theoretically, Sawston should be able to produce 4X Kite’s number, or 16,000 treatments annually using the whole Sawston facility, or the same number of treatments using 1/4 the space. (4,000 treatments using 11,000 square feet) But there’s more.
CAR-T manufacturers use individual all-in-one, end-to-end manufacturing work stations, which isn’t the most efficient use of space, as it ties up each individual work station during the long culturing step. If the Flaskworks system has one culture chamber, then the manufacturing capability would be approximately the same per space utilized. However, with Flaskworks system development, it’s conceivable that, by using larger media fill and waste tanks, and adding additional culture chambers and perfusion pumps, it could produce multiples of that in basically the same footprint. So by adding 10 culture chambers to each system for example, each manufacturing run could produce 10X the number of treatments in basically the same floor space. This might be what Michael Bigger was taking about when he said “cleanroom disruption.”
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM